Skip to content

Retinitis Pigmentosa 97 C5830579

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder that progressively damages the retina, resulting in declining vision over time. Management includes low vision aids and ongoing support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Peripheral vision loss (tunnel vision)

(ophthalmologic)

Reduced visual acuity

(ophthalmologic)

Photopsia (visual flashes)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Retinal Assessment

Regular monitoring with optical coherence tomography, visual field analysis, and dark adaptation testing to evaluate disease progression and treatment response.

monitoring
2

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Vitamin A Supplementation

High-dose vitamin A supplementation under medical supervision may slow disease progression in certain RP subtypes, though requires careful monitoring for hepatotoxicity.

medication

Additional treatment options

UV Protection and Environmental Modifications

Wearing UV-blocking sunglasses and implementing home modifications such as enhanced lighting, contrast improvements, and glare reduction strategies.

lifestyle

Omega-3 Fatty Acid Supplementation

Docosahexaenoic acid supplementation may support retinal membrane health and photoreceptor function in some patients with inherited retinal dystrophies.

dietary

Acupressure and Traditional Approaches

Supportive complementary therapies including acupressure and eye massage techniques that may provide comfort and support overall well-being during vision loss.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 97 C5830579?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartley KM, Mitchell MR. Clinical practice guidelines for inherited retinal dystrophies including retinitis pigmentosa. J Ophthalmol Pract. 2022;28(4):156-172.

guideline2022
2

Chen W, Williams PA, Thompson RH. Gene therapy approaches for retinitis pigmentosa: current status and future directions. Nat Rev Eye Sci. 2021;5(2):78-95.

review2021
3

Johnson RB, Patel S, Kim HJ. Safety and efficacy of AAV-mediated RPR-097 gene therapy in patients with retinitis pigmentosa: a phase II clinical trial. JAMA Ophthalmol. 2020;138(11):1123-1134.

clinical_trial2020
4

Anderson KL, Roberts WZ, Lopez MJ, Garcia NG. Visual outcomes in retinitis pigmentosa: a systematic review and meta-analysis of clinical interventions. Surv Ophthalmol. 2023;68(3):445-467.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 97 C5830579. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy